Daily Industry Report - August 25

Your summary of the Voluntary and Healthcare Industry’s most relevant and breaking news; brought to you by the Health & Voluntary Benefits Association®

Jake Velie, CPT
Vice Chairman & President
Health & Voluntary Benefits Association® (HVBA)
Editor-In-Chief
Daily Industry Report (DIR)

Robert S. Shestack, CCSS, CVBS, CFF
Chairman & CEO
Health & Voluntary Benefits Association® (HVBA)
Publisher
Daily Industry Report (DIR)

HVBA Innovation Summit Tampa Brings Industry Leaders Together for Education, Connection and an Unforgettable Casino Night

By HVBA – The Health & Voluntary Benefits Association® (HVBA) brought together brokers, consultants, industry leaders, innovators and strategic partners in Tampa for the 2026 HVBA Innovation Summit, delivering two days filled with meaningful conversations, timely education, relationship-building and plenty of fun. Read Full Article...

HVBA Article Summary

  1. Two-day summit combined education with intentional relationship-building: HVBA’s 2026 Innovation Summit in Tampa was structured around both learning and networking, with conversations designed to continue beyond formal programming. The event began with an invitation-only VIP dinner intended to help industry leaders connect before the main sessions started. Organizers framed the overall goal as creating conditions for introductions to develop into partnerships and practical collaboration. The structure emphasized ongoing engagement rather than a standalone conference experience.

  2. Sessions focused on current benefits challenges and operational innovation: Speakers addressed topics spanning employer health plan strategy, workforce aging and Medicare transitions, and ways to extract more value from existing benefit spend like unused paid time off. Other sessions centered on enrollment communication across a multi-generational workforce, including discussion of artificial intelligence use in the process. Prescription drug cost pressure and complexity were also highlighted through a panel explicitly focused on Rx spending and accountability. The programming presented multiple approaches to improving outcomes, costs, and employee experience through plan design and service models.

  3. Networking centerpiece was a casino-themed reception designed to keep attendees circulating: The agenda moved directly from education into an upscale Casino Night reception with food, an open bar, games, and prizes. The casino format was described as an intentional mechanism to encourage movement across the room and facilitate new connections between brokers, solution providers, and other professionals. HVBA leadership characterized the event’s success in terms of energy, learning, and business-relevant conversations rather than simply collecting contacts. The article positions this mix of content and networking as central to HVBA’s broader mission of education, innovation, and professional development.

HVBA Poll Question - Please share your insights

When a high-cost specialty drug or infusion claim hits your plan, what happens first?

Login or Subscribe to participate in polls.

Our last poll results are in!

27.34%

Of the Daily Industry Report readers who participated in our last polling question, when asked: “How confident are you that your employer clients know exactly who is Medicare eligible on their group health plan?” reported “Not very confident — we suspect there are gaps but haven't evaluated them.”

26.56% of DIR respondents reported “Not confident at all — we’ve never really looked into it,”  while 25% said “Very confident — we identify them and have a process for education and compliance,” and 21.10% claim “Somewhat confident — we know the numbers but don’t have a formal process.” Thank you to Aevitas for powering this polling question.

Have a poll question you’d like to suggest? Let us know!

Epic's Seth Howard on leadership changes and the company's vision to power AI across the health system

By Heather Landi – At its annual Users Group Meeting in Verona, Wisconsin, this week, Epic outlined its tech and AI strategy, signaling that the company has ambitions to be the operating system for healthcare. What wasn't addressed on stage—and likely on the minds of many attendees—was recent leadership changes at the company following a key executive departure. Last month, former President Sumit Rana announced he was stepping down for personal reasons after 28 years at the company. Rana was long considered to be CEO Judy Faulkner's successor. Read Full Article...

HVBA Article Summary

  1. Epic’s leadership transition emphasizes distributed responsibility: Rather than naming a single one-for-one replacement for former President Sumit Rana, Epic expanded responsibilities across four senior leaders, including Seth Howard. Howard characterized this as consistent with the company’s approach of flexible, employee-shaped roles rather than fixed career ladders. He also said Epic prioritizes developing leaders internally and does not typically recruit external executives to fill top roles.

  2. The company is positioning AI as a long-planned platform strategy, not a sudden pivot: Howard described Epic’s AI direction as a deliberate continuation of work that has been built up over years, alongside broader efforts to connect more of the healthcare ecosystem. He argued that Epic’s integrated approach—building software internally and keeping data consistent across applications—supports deploying AI and agentic workflows at scale. The strategy is framed as enabling AI to operate across clinical and operational workflows, not just as isolated point solutions.

  3. Epic is expanding tools for agentic AI, clinical prediction and IT automation—alongside real-world validation: The article highlights Epic’s Agent Factory as a platform for building, running and monitoring AI agents across workflows, with customers contributing a large volume of ideas following an Epic-hosted build-a-thon. Epic also described Cosmos Curiosity, a generative AI model trained on longitudinal real-world patient records and events to forecast what might happen next in a patient’s journey, with plans to integrate it into Epic’s EHR in March 2027. Separately, Epic introduced an “analyst build assistant” aimed at helping health system IT teams configure Epic faster, with Howard suggesting automation could shift staff time toward higher-value workflow design and clinician collaboration.

Supplemental benefits make consumer-driven health care work better

By Andrew Stocker – As consumer-driven health plans, or CDHPs, continue to gain traction, they're reshaping how employees engage with healthcare — and how employers think about benefits. Higher deductibles and greater cost-sharing have made health savings accounts an essential planning tool for employers offering high-deductible health plans.But HSAs alone may not minimize the financial impact employees can feel from out-of-pocket expenses, such as an HDHP's deductibles and copays, when an unexpected health event hits. That's where supplemental benefits come in. Read Full Article... (Subscription required)

HVBA Article Summary

  1. HSAs may not fully address out-of-pocket risk in CDHPs: The article argues that as CDHP enrollment grows, employees are taking on more direct responsibility for healthcare spending through higher deductibles and cost-sharing. While HSAs provide a tax-advantaged way to save and pay for eligible expenses, they may not fully protect employees from the financial shock of unexpected medical events. Supplemental benefits are presented as an additional mechanism to help manage that risk. The overall message is that employers can combine tools, rather than relying on HSAs alone, to support employees’ financial well-being.

  2. Supplemental benefits need to be understandable and easy to use to deliver value: The piece emphasizes that simply offering voluntary or supplemental products is insufficient if employees find them confusing or difficult to use. It highlights practical barriers such as understanding what is covered, how different benefits work together, and how to file claims. The author suggests employers and providers should focus on clear plan design, transparent language, and digital claims/payment experiences that reduce friction. It also notes that HSA usage should be similarly streamlined (for example, via simple reimbursement and payment options).

  3. Employees are asking for broader coverage and more choice across benefit types: The article cites survey results indicating strong demand for more voluntary benefit options among both HDHP and PPO enrollees (91% and 72%, respectively). It also contends that employees want benefits aligned with “real-life needs,” including women’s health, fertility and family-building, and more comprehensive mental health support. The author frames these areas as central to employee well-being rather than niche offerings. The conclusion is that pairing expanded supplemental benefits with HSAs and core medical coverage can make benefits feel integrated rather than optional add-ons.

30 large health systems growing bigger

By Alan Condon – After a brief post-pandemic lull, hospital consolidation is accelerating again, with large health systems expanding across state lines, absorbing independent hospitals and reshaping regional care markets. From portfolio resets and strategic exits to cross-market mergers and billion-dollar investments, these moves reflect how scale, capital access and geographic reach are becoming critical advantages in today’s healthcare landscape. Here are 30 large health systems that have announced or plan to close strategic mergers, acquisitions or partnerships this year. Editor’s note: This is not an exhaustive list. Read Full Article...

HVBA Article Summary

  1. Hospital Consolidation Continues Across Regional Markets: Health systems are actively pursuing acquisitions and affiliations to expand their geographic footprints, including deals involving Bon Secours Mercy Health, Kettering Health, WVU Health System, UPMC and Orlando Health. Several proposed combinations would move systems into new states or strengthen existing regional positions, while transactions such as Sutter Health’s planned acquisition of Allina Health would create a $26 billion organization with 39 hospitals. Many of these deals remain subject to regulatory, court or other approvals, with closings expected through late 2026 and early 2027.

  2. Health Systems Are Expanding Beyond Traditional Hospital Acquisitions: Transactions increasingly include ambulatory, urgent care and behavioral health assets in addition to hospitals, reflecting broader efforts to build integrated care networks. Ascension completed a $3.9 billion acquisition of AmSurg that expanded its network to 300 ambulatory surgery centers, HCA Healthcare acquired 17 urgent care clinics in the Carolinas, and Universal Health Services plans to acquire Talkspace for $835 million. These deals suggest systems are using acquisitions to expand outpatient and digital capabilities alongside their inpatient operations.

  3. Large-Scale Partnerships Are Bringing Significant Capital Commitments: Several proposed transactions include substantial investments intended to support expansion, modernization and financial stability at acquired or affiliated organizations. Prisma Health’s proposed acquisition of Erlanger Health includes $2 billion in capital investment, RWJBarnabas Health plans approximately $500 million in investments tied to Englewood Health, and Maimonides could receive up to $2.2 billion over five years through a state grant associated with its planned acquisition by NYC Health + Hospitals. Other arrangements, including Rochester Regional Health’s proposed affiliation with bankrupt North Star Health Alliance, also rely on state funding and restructuring efforts to support financially challenged providers.

Forging stronger broker-TPA partnerships

By Bruce Shutan – Third-party administrators (TPAs) wield tremendous power in today's healthcare ecosystem, serving as the operational hub for cost-containment efforts at a time when self-insuring group health benefits continues to trickle down market. In this intensifying climate, rising healthcare costs and limited internal HR capacity are driving demand for stronger partnerships between brokers and TPAs to deliver actionable insights, strategic guidance, and administrative support, according to a recent report by Nova Healthcare Administrators Inc., a leading TPA. Read Full Article... (Subscription required)

HVBA Article Summary

  1. TPAs’ expanding role in cost containment: The article argues that TPAs increasingly function as the operational center for employer health-plan cost-control efforts, especially as self-insurance reaches smaller segments of the market. It frames this as a response to ongoing healthcare cost pressure and employers’ limited in-house HR bandwidth. A Nova Healthcare Administrators report is cited as a key source supporting the need for closer broker–TPA coordination. The emphasis is on pairing administration with actionable insights and strategic guidance rather than treating TPAs as back-office processors.

  2. Plan affordability pressures are pushing benefit redesign: A cited example highlights how high-cost specialty drugs can destabilize renewals for smaller groups, creating volatility that traditional group plans may struggle to absorb. In response, the article notes that some employers are moving away from group health plans and adopting an individual coverage health reimbursement arrangement (ICHRA), setting a defined dollar contribution for employees to buy individual-market coverage. This shift is presented as a practical alternative for employers facing unpredictable claims risk. The broader point is that employers are exploring different funding and delivery models as sustainability concerns grow.

  3. Execution capability and alignment matter in broker–TPA relationships: Sources quoted in the article stress that solutions can fail without clear communication and a realistic understanding of what a given TPA can administer, adjudicate, and monitor. The piece outlines a range of cost-management approaches where coordination is critical, including incentives for using high-quality providers, centers of excellence, direct primary care, and direct provider contracting. It also raises the idea that ownership structure (nonprofit vs. insurer-owned or private-equity-owned) can affect a TPA’s flexibility and independence. Brokers are portrayed as needing to verify not just what TPAs claim they can do, but what they can consistently execute in practice.

Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance

By Siddhi Mahatole – The U.S. Food and Drug Administration has cleared Roche (ROPC.S), and partner Eli Lilly's (LLY.N), blood test to help identify signs of Alzheimer's disease in people aged ‌55 and older with cognitive decline. The test, Elecsys pTau217, is a biomarker blood test that can help doctors identify patients who are likely or unlikely to have Alzheimer's-related brain changes, Roche said on Monday. The FDA clearance follows European ⁠approval for the test in May. Read Full Article...

HVBA Article Summary

  1. What the FDA cleared and who it is for: The FDA cleared Roche and Eli Lilly’s Elecsys pTau217 blood test to help identify signs of Alzheimer’s disease in people 55 and older who have cognitive decline. Roche described it as a biomarker test that helps clinicians assess whether a patient is likely or unlikely to have Alzheimer’s-related brain changes. The clearance comes after the test received European approval earlier in the year. The article frames the decision as part of a broader push toward easier-to-use Alzheimer’s diagnostics.

  2. How the test could scale in U.S. labs: Roche said the test can be run on more than 4,500 Roche laboratory analyzers already installed across the United States. Labcorp and Quest Diagnostics also said they plan to offer the test through their laboratory networks. Together, these distribution channels could make the test more widely available than some existing diagnostic approaches. Roche did not disclose pricing in the announcement.

  3. Context vs. existing diagnostic options and limitations: The story notes that current ways to detect amyloid—a protein linked to Alzheimer’s—often rely on PET scans or cerebrospinal fluid testing, which can be expensive, invasive, and less widely available. Reuters also points to competition in the space, citing Fujirebio's Lumipulse as the first FDA-cleared blood test for Alzheimer’s assessment in 2025. Roche cautioned that Elecsys pTau217 is not intended to be used as a standalone diagnostic. Results should be interpreted alongside other clinical information, according to the company.

Employer healthcare expenses could spike 9.5% in 2027, pressured by GLP-1s

By Chad Van Alstin – Employers can expect healthcare costs for their workers to rise by 9.5% next year, pushing the average per-employee expenditure above $19,000, a new report from business intelligence firm Aon reveals. In an announcement, the group outlined how even efforts to contain costs have not been enough in recent years to stop employers and employees from absorbing the burden of healthcare price inflation. Since 2022, employer healthcare costs have “more than doubled,” spiking from 3.7% to now 8.8% in 2026. As Aon noted, employers are responsible for roughly 82% of the cost to provide their staff with medical insurance, and ultimately cannot take on the full burden of rising premiums. Read Full Article...

HVBA Article Summary

  1. Sustained, near–double-digit health inflation is shaping benefits decisions: Aon frames its forecast as part of a multi-year trend where annual cost growth has stayed unusually high. The company argues this is no longer just a budgeting issue and increasingly affects benefits strategy, employee affordability, and broader workforce planning. The report also characterizes the current environment as one of the most prolonged periods of employer healthcare inflation in decades.

  2. Workers may face uneven cost impacts depending on the employer: Aon reported that the middle 50% of employers saw healthcare cost increases ranging from 5.5% to 11.5%, indicating wide variation in pressure across organizations. That spread suggests that plan design, workforce health, local market pricing, and vendor contracts can significantly influence outcomes. As a result, employee out-of-pocket exposure and benefit changes may differ substantially from one employer to another.

  3. Chronic conditions and rising drug spend—especially GLP-1s—are key utilization drivers: Aon points to higher prevalence of chronic illness as a factor increasing healthcare utilization and the frequency of high-cost claims. It also highlights ongoing growth in prescription drug spending, with employer plans feeling pressure to cover expensive GLP-1 therapies as use expands. The report notes that emerging oral formulations could broaden access further, forcing employers to weigh access, affordability, and long-term sustainability.

The demographic wave you can't ignore

By Chuck Greenblott – Here's a question I don't hear enough benefits advisers asking their HR clients: "Of your employees over 50, how many have no adult children living nearby or none at all?" Most can't answer that. They've never thought to track it. And that's a problem because that population is growing faster than almost any other segment of the workforce. Let me offer a number that should stop you cold: Nearly one in five women over 45 in the U.S. has no biological children. It's even higher among certain age cohorts and demographics. Add in divorce, widowhood and adult children who live across the country and you've got a massive and rapidly expanding group of employees who are going to age without a family safety net. Read Full Article... (Subscription required)

HVBA Article Summary

  1. Solo Aging Is Creating a Growing Benefits and Planning Gap: A rising number of older adults are approaching retirement without nearby children or family members who can help coordinate healthcare, finances, and daily needs. Many existing workplace benefits and planning models assume a family caregiver will be available, potentially leaving solo agers without adequate support. The article projects that by 2030, solo agers will represent one of the largest demographic groups in the American workforce.

  2. Employers May Need to Adapt Benefits for Employees Without Family Caregivers: Employers and advisers can begin by assessing how many older employees live alone, lack nearby family, or otherwise expect to manage aging independently. Potential support could include care-navigation services that do not depend on family involvement, access to professional advocates or fiduciaries, and financial solutions incorporating professional care management. These approaches could broaden existing caregiving benefits beyond traditional family structures.

  3. Earlier Planning Could Help Solo Agers Prepare for Future Care Needs: Solo agers may need to make advance decisions about who will manage healthcare, finances, and caregiving if they become unable to do so themselves. Benefits education, employee resource groups, and individual planning conversations could provide opportunities to discuss these issues and identify available resources. Greater awareness and preparation may help employees establish support systems before significant health, financial, or caregiving needs arise.